Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Work In Process (2020 - 2025)

Historic Work In Process for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $9.7 million.

  • Maravai Lifesciences Holdings' Work In Process fell 973.2% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 973.2%. This contributed to the annual value of $10.0 million for FY2024, which is 2074.13% down from last year.
  • Maravai Lifesciences Holdings' Work In Process amounted to $9.7 million in Q3 2025, which was down 973.2% from $10.5 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Work In Process ranged from a high of $30.6 million in Q3 2022 and a low of $9.7 million during Q3 2025
  • In the last 5 years, Maravai Lifesciences Holdings' Work In Process had a median value of $14.5 million in 2023 and averaged $17.3 million.
  • Its Work In Process has fluctuated over the past 5 years, first surged by 3073.18% in 2022, then crashed by 6005.95% in 2023.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Work In Process stood at $21.4 million in 2021, then grew by 2.66% to $22.0 million in 2022, then tumbled by 42.23% to $12.7 million in 2023, then fell by 20.74% to $10.0 million in 2024, then fell by 3.46% to $9.7 million in 2025.
  • Its last three reported values are $9.7 million in Q3 2025, $10.5 million for Q2 2025, and $9.9 million during Q1 2025.